Imprimis Pharmaceuticals (NASDAQ: IMMY) is a specialty pharmaceutical company focused on the development, production and dispensing of novel compounded pharmaceuticals. The company’s two business programs, Imprimis Cares™ and Custom Compounding Choice™, focus on patient outcomes and affordability by offering high … Continue reading →

MyDx (OTC: MYDX) is a chemical detection and sensor technology company whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The company’s MyDx product is a patented, affordable portable analyzer that provides … Continue reading →

CAS Medical Systems (NASDAQ: CASM) is a leader in non-invasive patient monitoring of cerebral oxygenation. The company’s FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for patients during critical care. Direct monitoring … Continue reading →

Resonant (NASDAQ: RESN) is a late-stage development company creating innovative filter designs for radio frequency front-ends (RFFEs) for the mobile device industry. The RFFE is the circuitry in a mobile device responsible for analog signal processing. Filters are a critical … Continue reading →

Dataram (NASDAQ: DRAM) is an independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops sold by leading manufacturers. Dataram’s memory products and solutions are … Continue reading →

Sysorex (NASDAQ: SYRX) develops systems and solutions that power the data-driven enterprise. The company blends virtual data from software and networks with the huge volume of physical data generated by mobile devices and Internet-connected things to open new worlds of … Continue reading →

Signal Genetics (NASDAQ: SGNL) is a commercial-stage molecular design company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company’s lead product is its MyPRS® test, which … Continue reading →

Biolase (NASDAQ: BIOL) is a medical device company that develops, manufactures, markets and sells laser systems for dentistry and medicine and also markets, sells and distributes dental imaging equipment. The company’s proprietary laser products incorporate approximately 250 patented and 90 … Continue reading →

Delcath Systems (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focused on oncology and the treatment of primary and metastatic liver cancers. The company’s proprietary Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) … Continue reading →

FTE Networks (OTC: FTNW), together with its subsidiaries, provides international and regional telecommunications and technology systems, and infrastructure services. The company specializes in the design, engineering, installation and maintenance of various forms of telecommunications infrastructure, also provides wireless solutions to … Continue reading →